JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamieson, W. R.
Right arrow Articles by Tyers, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jamieson, W. R.
Right arrow Articles by Tyers, G. F.

The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 543-561, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

The Carpentier-Edwards standard porcine bioprosthesis. A first- generation tissue valve with excellent long-term clinical performance

WR Jamieson, P Allen, RT Miyagishima, AN Gerein, AI Munro, LH Burr and GF Tyers
Department of Surgery, University of British Columbia, Vancouver, Canada.

The Carpentier-Edwards standard porcine bioprosthesis was implanted in 1190 patients (1201 operations, 1303 valves) between January 1975 and June 1986; most implants were before 1982. The mean age of the patients was 57.2 years (range 8 to 85 years). The early mortality was 7.6% (aortic valve replacement 5.1%, mitral valve replacement 8.8%, and multiple valve replacement 15.3%). Late mortality was 3.9% per patient- year (aortic valve replacement 3.6%, mitral valve replacement 4.2%, and multiple valve replacement 3.8%). The total cumulative follow-up period was 6737 years. Thromboembolism was 1.5% per patient-year (fatal 0.4% per patient-year) (minor 0.6%, major 0.9%); antithromboembolic therapy- related hemorrhage was 0.5% (fatal 0.1%); prosthetic valve endocarditis was 0.6% (fatal 0.2%); nonstructural dysfunction was 0.5% (fatal 0.2%); and structural valve deterioration and/or primary tissue failure was 1.5% per patient-year (fatal, 0.2% per patient-year). Thromboembolism and structural valve deterioration were the significant complications, structural valve deterioration occurring primarily between the sixth and 10th year of evaluation. The overall patient survival was 65.0% for aortic valve replacement and 54.8% for mitral valve replacement (p less than 0.05) at 10 years. The patients were classified as 92.9% New York Heart Association functional classes III and IV preoperatively and 92.3% classes I and II postoperatively. Freedom at 10 years from thromboembolism was 84.3% for aortic valve replacement and 76.5% for mitral valve replacement (p = 0.05); structural valve deterioration was 78.6% for aortic valve replacement and 71.6% for mitral valve replacement (p less than 0.05); reoperation was 74.4% for aortic valve replacement and 67.1% for mitral valve replacement (p less than 0.05). Freedom from all valve-related complications at 10 years was 58.9% for aortic valve replacement and 46.8% for mitral valve replacement (p less than 0.05); valve-related mortality was 89.5% for aortic valve replacement and 82.6% for mitral valve replacement (p = not significant); mortality and reoperation was 58.9% for aortic valve replacement and 46.8% for mitral valve replacement (p less than 0.05); mortality and residual morbidity (treatment failure) was 87.2% for aortic valve replacement and 75.1% for mitral valve replacement (p = not significant); mortality, residual morbidity, and reoperation were 66.3% for aortic valve replacement and 54.9% for mitral valve replacement (p less than 0.05). The standard Carpentier-Edwards porcine bioprosthesis has provided satisfactory clinical performance and has afforded patients excellent quality of life.


This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
F.-C. Riess, E. Cramer, L. Hansen, S. Schiffelers, G. Wahl, J. Wallrath, S. Winkel, and P. Kremer
Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years
Eur J Cardiothorac Surg, January 1, 2010; 37(1): 145 - 153.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F.-C. Riess, R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese
Hemodynamic Performance of the Medtronic Mosaic Porcine Bioprosthesis Up to Ten Years
Ann. Thorac. Surg., April 1, 2007; 83(4): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. Lund and M. Bland
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement
J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 20 - 26.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Gao, Y. Wu, G. L. Grunkemeier, A. P. Furnary, and A. Starr
Durability of pericardial versus porcine aortic valves
J. Am. Coll. Cardiol., July 21, 2004; 44(2): 384 - 388.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. A. Marchand, M. R. Aupart, R. Norton, I. R.A. Goldsmith, L. C. Pelletier, M. Pellerin, T. Dubiel, W. J. Daenen, P. Herijgers, F. P. Casselman, et al.
Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis
Ann. Thorac. Surg., May 1, 2001; 71(2007): S236 - S239.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. A. Puvimanasinghe, E. W. Steyerberg, J. J. M. Takkenberg, M. J. C. Eijkemans, L. A van Herwerden, A. J. J. C. Bogers, and J. D. F. Habbema
Prognosis After Aortic Valve Replacement With a Bioprosthesis : Predictions Based on Meta-Analysis and Microsimulation
Circulation, March 20, 2001; 103(11): 1535 - 1541.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. E. David, J. Ivanov, S. Armstrong, C. M. Feindel, and G. Cohen
Late results of heart valve replacement with the Hancock II bioprosthesis
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0268 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Cohen, T. E. David, J. Ivanov, S. Armstrong, and C. M. Feindel
THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 273 - 284.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. S. U. Myken, Håk. E. Berggren, S. Larsson, B. Roberts, I. Wallentin, and K. Caidahl
LONG-TERM DOPPLER ECHOCARDIOGRAPHIC RESULTS OF AORTIC OR MITRAL VALVE REPLACEMENT WITH BIOCOR PORCINE BIOPROSTHESIS
J. Thorac. Cardiovasc. Surg., October 1, 1998; 116(4): 599 - 608.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
J. W. Borowiec, T. W. Dubiel, H.-E. Hansson, J. Landelius, S.-O. Nystrom, and J. W. Borowiec
Pericarbon Pericardial Valve Prosthesis: Midterm Results of the Aortic Valve Replacement
Angiology, January 1, 1998; 49(1): 1 - 11.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. R. Aupart, P. H. Neville, S. Hammami, A. L. Sirinelli, Y. A. Meurisse, and M. A. Marchand
CARPENTIER-EDWARDS PERICARDIAL VALVES IN THE MITRAL POSITION: TEN-YEAR FOLLOW-UP
J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 492 - 498.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
W. R. Eric Jamieson, A. I. Munro, R. T. Miyagishima, P. Allen, L. H. Burr, and G. F. O. Tyers
Carpentier-edwards standard porcine bioprosthesis: Clinical performance to seventeen years
Ann. Thorac. Surg., October 1, 1995; 60(4): 999 - 1007.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. J. Edwards, S. A. Livesey, I. A. Simpson, J. L. Monro, and J. Keith Ross
Biological valves beyond fifteen years: The wessex experience
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S211 - S215.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. David, S. Armstrong, and Z. Sun
The Hancock II bioprosthesis at ten years
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S229 - S234.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. R. Eric Jamieson, L. H. Burr, G. Frank, O. Tyers, R. T. Miyagishima, M. T. Janusz, H. Ling, G. J. Fradet, J. MacNab, F. Chan, et al.
Carpentier-Edwards supraannular porcine bioprosthesis: Clinical performance to twelve years
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S235 - S240.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. R. Eric Jamieson, L. H. Burr, R. T. Miyagishima, G. J. Fradet, M. T. Janusz, G. Frank, O. Tyers, J. MacNab, and F. Chan
Structural deterioration in Carpentier-Edwards standard and supraannular porcine bioprostheses
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S241 - S247.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Bernal, J. M. Rabasa, R. Lopez, J. Francisco Nistal, R. Muniz, and J. M. Revuelta
Durability of the Carpentier-Edwards porcine bioprosthesis: Role of age and valve position
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S248 - S252.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. D. Lemieux, W. R. Eric Jamieson, R. W. Landymore, J. G. Dumesnil, J. Metras, A. Ian Munro, G. Raymond, G. Frank, O. Tyers, P. C. Cartier, et al.
Medtronic intact porcine bioprosthesis: Clinical performance to seven years
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S258 - S263.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Pellerin, S. Mihaileanu, J. Paul Couetil, J. Y. M. Relland, A. Deloche, J.-N. Fabiani, A. Jindani, and A. F. Carpentier
Carpentier-edwards pericardial bioprosthesis in aortic position: Long-term follow-up 1980 to 1994
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S292 - S296.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. A. Talman and D. R. Boughner
Glutaraldehyde fixation alters the internal shear properties of porcine aortic heart valve tissue
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S369 - S373.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. J. Fradet, W. R. Eric Jamieson, J. G. Abel, S. V. Lichtenstein, R. T. Miyagishima, H. Ling, G. Frank, and O. Tyers
Clinical performance of biological and mechanical prostheses
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S453 - S458.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. D. Glower, W. D. White, A. C. Hatton, L. R. Smith, W. G. Young, W. G. Wolfe, and J. E. Lowe
Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 381 - 393.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
K. J. Lockie, M. Butterfield, J. Fisher, N. P. Juster, K. watterson, and G. A. Davies
Geometry of homograft valve leaflets: Effect of dilation of the aorta and the aortic root
Ann. Thorac. Surg., July 1, 1993; 56(1): 125 - 130.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. David, S. Armstrong, and Z. Sun
Clinical and hemodynamic assesment of the Hancock II bioprosthesis
Ann. Thorac. Surg., October 1, 1992; 54(4): 661 - 668.
[Abstract] [PDF]


Home page
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in MedicineHome page
J. Fisher, M. Butterfield, K. J. Lockie, and G. A. Davies
A Model of the Geometrical Changes in Aortic Valve Leaflets in Response to Leaflet Extension and Variable Boundary Conditions
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, March 1, 1992; 206(1): 7 - 14.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The American Association for Thoracic Surgery.